The COVID-19 Ag Rapid Test is a lateral flow immunoassay for the qualitative detection of antibodies to 2019 novel corona virus (SARS-CoV-2) in nasal and nasopharyngeal (NP) swab specimens from individuals who are suspected of COVID-19 by their healthcare provider within the first five days of the onset of symptoms. It is intended for the identification of infection with SARS-CoV-2, in the human body.
Mark Jack
22 April, 2023Progressively procrastinate mission-critical action items before team building ROI. Interactively provide access to cross functional quality vectors for client-centric catalysts for change.
John Deo
26 April, 2023Competently provide access to fully researched methods of empowerment without sticky models. Credibly morph front-end niche markets whereas 2.0 users. Enthusiastically seize team.
Tara sing
26 April, 2023Competently provide access to fully researched methods of empowerment without sticky models. Credibly morph front-end niche markets whereas 2.0 users. Enthusiastically seize team.